日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Machine Learning Improves Risk Stratification in Myelofibrosis: An Analysis of the Spanish Registry of Myelofibrosis

机器学习改善骨髓纤维化风险分层:西班牙骨髓纤维化登记研究分析

Mosquera-Orgueira, Adrián; Pérez-Encinas, Manuel; Hernández-Sánchez, Alberto; González-Martínez, Teresa; Arellano-Rodrigo, Eduardo; Martínez-Elicegui, Javier; Villaverde-Ramiro, Ángela; Raya, José-María; Ayala, Rosa; Ferrer-Marín, Francisca; Fox, María-Laura; Velez, Patricia; Mora, Elvira; Xicoy, Blanca; Mata-Vázquez, María-Isabel; García-Fortes, María; Angona, Anna; Cuevas, Beatriz; Senín, María-Alicia; Ramírez-Payer, Angel; Ramírez, María-José; Pérez-López, Raúl; González de Villambrosía, Sonia; Martínez-Valverde, Clara; Gómez-Casares, María-Teresa; García-Hernández, Carmen; Gasior, Mercedes; Bellosillo, Beatriz; Steegmann, Juan-Luis; Álvarez-Larrán, Alberto; Hernández-Rivas, Jesús María; Hernández-Boluda, Juan Carlos

Real-life analysis on safety and efficacy of asciminib for ponatinib pretreated patients with chronic myeloid leukemia

对既往接受过帕纳替尼治疗的慢性粒细胞白血病患者使用阿西米尼的安全性和有效性进行真实世界分析

Luna, A; Pérez-Lamas, L; Boque, C; Giraldo, P; Xicoy, B; Ruiz Nuño, C; Vega, M Moreno; Alvarez-Larrán, A; Salamanca, A; García-Noblejas, A; Vall-Llovera, F; Villalon, L; De Las Heras, N; Ramila, E; Pérez-Encinas, M; Cuevas, B; Perez-Lopez, R; Sanchez-Guijo, F; Jiménez-Velasco, A; Lakhwani, S; Casado, L Felipe; Rosell, A; Escola, A; Fernández, M J; Garcia-Hernandez, C; Cervero, C; Mora, E; Sagüés, M; Suarez-Varela, S; Vélez, P; Carrascosa Mastell, P; Bitaube, R F; Serrano, L; Cortes, M; Vera Goñi, J A; Steegmann, J L; de Soria, V Gomez Garcia; Alonso-Dominguez, J M; Araujo, M Colorado; Coll, A Paz; Hernandez-Boluda, J C; García-Gutiérrez, V

Safety and efficacy of asciminib treatment in chronic myeloid leukemia patients in real-life clinical practice

在真实临床实践中,asciminib治疗慢性粒细胞白血病患者的安全性和有效性

Garcia-Gutiérrez, Valentín; Luna, Alejandro; Alonso-Dominguez, Juan M; Estrada, Natalia; Boque, Concepcion; Xicoy, Blanca; Giraldo, Pilar; Angona, Anna; Alvarez-Larrán, Alberto; Sanchez-Guijo, Fermin; Ramírez, María José; Mora, Elvira; Vélez, Patricia; Rosell, Ana; Colorado Araujo, Mercedes; Cuevas, Beatriz; Sagüés, Miguel; Cortes, Montserrat; Encinas, Manuel Perez; Casado Montero, Luis Felipe; Moreno Vega, Melania; Serrano, Luis; Gomez, Valle; Garcia-Hernandez, Carmen; Lakhwani, Sunil; Paz Coll, Antonio; de Paz, Raquel; Suarez-Varela, Sara; Fernandez-Ruiz, Andrés; Perez Lopez, Raul; Ortiz-Fernández, Almudena; Jiménez-Velasco, Antonio; Steegmann-Olmedillas, Juan Luis; Hernández-Boluda, Juan Carlos

European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia

欧洲白血病网2020年慢性粒细胞白血病治疗建议

Hochhaus, A; Baccarani, M; Silver, R T; Schiffer, C; Apperley, J F; Cervantes, F; Clark, R E; Cortes, J E; Deininger, M W; Guilhot, F; Hjorth-Hansen, H; Hughes, T P; Janssen, J J W M; Kantarjian, H M; Kim, D W; Larson, R A; Lipton, J H; Mahon, F X; Mayer, J; Nicolini, F; Niederwieser, D; Pane, F; Radich, J P; Rea, D; Richter, J; Rosti, G; Rousselot, P; Saglio, G; Saußele, S; Soverini, S; Steegmann, J L; Turkina, A; Zaritskey, A; Hehlmann, R

Effective quantification of 11 tyrosine kinase inhibitors and caffeine in human plasma by validated LC-MS/MS method with potent phospholipids clean-up procedure. Application to therapeutic drug monitoring

采用经过验证的 LC-MS/MS 方法和强效磷脂净化程序,有效定量人类血浆中的 11 种酪氨酸激酶抑制剂和咖啡因。应用于治疗药物监测

Dora Koller, Viktoryia Vaitsekhovich, Cecile Mba, Juan L Steegmann, Pablo Zubiaur, Francisco Abad-Santos, Aneta Wojnicz

Cytotoxic cell populations developed during treatment with tyrosine kinase inhibitors protect autologous CD4+ T cells from HIV-1 infection

酪氨酸激酶抑制剂治疗期间产生的细胞毒性细胞群可保护自体CD4+ T细胞免受HIV-1感染。

Vigón, Lorena; Rodríguez-Mora, Sara; Luna, Alejandro; Sandonís, Virginia; Mateos, Elena; Bautista, Guiomar; Steegmann, Juan Luis; Climent, Nuria; Plana, Montserrat; Pérez-Romero, Pilar; de Ory, Fernando; Alcamí, José; García-Gutierrez, Valentín; Planelles, Vicente; López-Huertas, María Rosa; Coiras, Mayte

Asciminib in Chronic Myeloid Leukemia after ABL Kinase Inhibitor Failure

阿西米尼用于ABL激酶抑制剂治疗失败后的慢性粒细胞白血病

Hughes, Timothy P; Mauro, Michael J; Cortes, Jorge E; Minami, Hironobu; Rea, Delphine; DeAngelo, Daniel J; Breccia, Massimo; Goh, Yeow-Tee; Talpaz, Moshe; Hochhaus, Andreas; le Coutre, Philipp; Ottmann, Oliver; Heinrich, Michael C; Steegmann, Juan L; Deininger, Michael W N; Janssen, Jeroen J W M; Mahon, Francois-Xavier; Minami, Yosuke; Yeung, David; Ross, David M; Tallman, Martin S; Park, Jae H; Druker, Brian J; Hynds, David; Duan, Yuyan; Meille, Christophe; Hourcade-Potelleret, Florence; Vanasse, K Gary; Lang, Fabian; Kim, Dong-Wook

Immediate Effects of Dasatinib on the Migration and Redistribution of Naïve and Memory Lymphocytes Associated With Lymphocytosis in Chronic Myeloid Leukemia Patients

达沙替尼对慢性粒细胞白血病患者淋巴细胞增多症相关幼稚淋巴细胞和记忆淋巴细胞迁移和重新分布的即时影响

Beatriz Colom-Fernández ,Anna Kreutzman ,Ana Marcos-Jiménez ,Valentín García-Gutiérrez ,Carlos Cuesta-Mateos ,Itxaso Portero-Sainz ,Yaiza Pérez-García ,Luis Felipe Casado ,Fermín Sánchez-Guijo ,Joaquín Martínez-López ,Rosa M Ayala ,Concha Boqué ,Blanca Xicoy ,Isabel Montero ,César Soto ,Raquel Paz ,Gabriela Silva ,Lorena Vega-Piris ,Juan Luis Steegmann ,Cecilia Muñoz-Calleja

Feasibility of treatment discontinuation in chronic myeloid leukemia in clinical practice: results from a nationwide series of 236 patients

慢性粒细胞白血病临床实践中停药的可行性:一项纳入全国236例患者的研究结果

Hernández-Boluda, Juan Carlos; Pereira, Arturo; Pastor-Galán, Irene; Alvarez-Larrán, Alberto; Savchuk, Alisa; Puerta, José Manuel; Sánchez-Pina, José María; Collado, Rosa; Díaz-González, Alvaro; Angona, Anna; Sagüés, Miguel; García-Gutiérrez, Valentín; Boqué, Concepción; Osorio, Santiago; Vallansot, Rolando; Palomera, Luis; Mendizábal, Arantxa; Casado, Luis Felipe; Pérez-Encinas, Manuel; Pérez-López, Raúl; Ferrer-Marín, Francisca; Sánchez-Guijo, Fermín; García, Carmen; Heras, Natalia de Las; López-Lorenzo, José Luis; Cervantes, Francisco; Steegmann, Juan Luis

Correction to: An analysis of the kinetics of molecular response during the first trimester of treatment with nilotinib in newly diagnosed chronic myeloid leukemia patients in chronic phase

更正:对新诊断的慢性粒细胞白血病慢性期患者接受尼洛替尼治疗第一个三个月期间分子反应动力学的分析

Steegmann, Juan Luis; Colomer, Dolors; Gómez-Casares, Maria-Teresa; García-Gutiérrez, Valentín; Ortí, Guillermo; Ramírez-Payer, Angel; Olavarria, Eduardo; Vall-Llovera, Ferrán; Giraldo, Pilar; Conde, Eulogio; Vallansot, Rolando; López-Lorenzo, Jose Luis; Palomera, Luis; Álvarez-Larrán, Alberto; Conesa, Venancio; Bautista, Guiomar; Casas, Laura; Giles, Frank; Hochhaus, Andreas; Casado-Montero, Luis Felipe